Synthesis and biological evaluation of 1,2,4-triazoloazines as potent anticancer agents-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of 1,2,4-triazoloazines as potent anticancer agents

Published:2023 Issue:39 Volume:47 Page:18325-18331
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Serebrennikova Polina O.¹^ORCID,Paznikova Julia A.¹,Kirnos Eva A.¹,Utepova Irina A.¹²³^ORCID,Kazakova Elizaveta D.¹,Lazarev Vladimir F.⁴,Kuznetcova Liubov S.⁴^ORCID,Margulis Boris A.⁴,Guzhova Irina V.⁴,Chupakhin Oleg N.¹³^ORCID,Sarapultsev Alexey P.²

Affiliation:

1. Department of Organic and Biomolecular Chemistry, Ural Federal University, 28 Mira str., 620002, Ekaterinburg, Russia

2. Russian-Chinese Center of Systemic Pathology, South Ural State University, 76, Lenin Prospekt, Chelyabinsk 454080, Russia

3. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 22 S. Kovalevskoy str., 620108, Ekaterinburg, Russia

4. Institute of Cytology of the Russian Academy of Sciences, 4 Tikhoretsky av., 194064, St-Petersburg, Russia

Abstract

The new derivatives of mono- and bis-1,2,4-triazoloazines were obtained. The cytotoxic activity of the compounds was evaluated against the cancer cell lines.

Funder

Russian Science Foundation

Ministry of Education and Science of the Russian Federation

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NJ/D3NJ03158F

Reference32 articles.

1. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities

2. Cancer statistics, 2020

3. New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics

4. Cancer statistics, 2019

5. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050